Analyst Robyn Karnauskas of Deutsche Bank said Gilead Sciences’ (NASADQ:GILD) Atripla recall was not an issue. 39,233 bottles were recalled on Feb 19th because of red silicone rubber particulates found in drug, according to an FDA enforcement report. Gilead Sciences, Inc. (NASDAQ:GILD) stock opened at $81.21 in last session, and closed at $79.58, while the day range of Gilead Sciences, Inc. (NASDAQ:GILD) stock is $77.81 – $81.35. The stock showed a positive weekly performance of -3.88%.
Pfizer Inc. (NYSE:PFE) has issued a recall for the antidepressant Effexor (venlafaxine HCI), because it may have been contaminated with a heart drug. Pfizer Inc. (NYSE:PFE) stock opened at $32.51 in last session, and closed at $32.43 by losing -0.09%. The 52 week range of $27.12 – $32.96. Company’s market capitalization is $208.95 billion.
Boston Scientific Corp. logo Boston Scientific Corp. (NYSE:BSX) EVP Michael Phalen sold 7,281 shares of the stock in a transaction that occurred on Thursday, March 6th. Boston Scientific Corporation (NYSE:BSX) stock increased 1.11% and finished the last session at $13.70. The EPS of the stock remained -0.09. Company’s market capitalization is $18.21 billion.
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) on Feb. 25 reported financial results for the fourth quarter and full year ended December 31, 2013 and provided an update on corporate developments. Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) stock opened the session at $8.41, and closed the session at $8.13. The 52 week range of the Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) stock remained $2.15 – $23.00 and the day range was $8.08 – $8.48.
Leave a Reply